Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Zoetis    ZTS

ZOETIS

(ZTS)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/19/2020 11/20/2020 11/23/2020 11/24/2020 11/25/2020 Date
166.31(c) 166.2(c) 164.34(c) 161.06(c) 160.19(c) Last
1 329 244 1 217 711 1 493 220 2 425 927 1 981 777 Volume
+1.72% -0.07% -1.12% -2.00% -0.54% Change
More quotes
Financials (USD)
Sales 2020 6 606 M - -
Net income 2020 1 659 M - -
Net Debt 2020 3 277 M - -
P/E ratio 2020 47,2x
Yield 2020 0,49%
Sales 2021 7 096 M - -
Net income 2021 1 882 M - -
Net Debt 2021 2 436 M - -
P/E ratio 2021 40,0x
Yield 2021 0,57%
Capitalization 76 703 M 76 703 M -
EV / Sales 2020 12,1x
EV / Sales 2021 11,2x
Nbr of Employees 10 600
Free-Float 94,6%
More Financials
Company
Zoetis specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (50.2%): cats and dogs (93.8% of net sales) and horses (6.2%); - livestock (48.4%): cattle (54.6% of sales), swine (20.2%), poultry (18.4%), fish (4.4%) and other (2.4%); - other (1.4%). Net sales break down by family of products into vaccines (23.7%), antiinfectives (20%),... 
More about the company
Notations Surperformance© of Zoetis
Trading Rating : Investor Rating :
More Ratings
All news about ZOETIS
11/17ZOETIS : Researchers and Scientists Present at 6th World One Health Congress
PU
11/16ZOETIS : is First Animal Health Company to Issue Environmental, Social and Gover..
BU
11/12ZOETIS : Receives European Commission Marketing Authorization for Librela® (bedi..
BU
11/05Zoetis CFO Boosts Third-Party Orders as Pet Owners Drive Sales
DJ
11/05ZOETIS : Management's Discussion and Analysis of Financial Condition and Results..
AQ
11/05Today on Wall Street: Alibaba, Bristol-Myers Squibb, T-Mobile US…
11/05ZOETIS : Increases Fiscal Year Outlook
DJ
11/05ZOETIS : 3Q Net Profit, Revenue Climb
DJ
11/05ZOETIS : 3Q Earnings Snapshot
AQ
11/05ZOETIS INC. : Results of Operations and Financial Condition (form 8-K)
AQ
11/05ZOETIS : Announces Third Quarter 2020 Results
BU
11/04Soybeans Higher on Brazilian Weather Woes
DJ
11/02ZOETIS : quaterly earnings release
10/26ZOETIS : to Participate in the Credit Suisse 2020 Virtual Healthcare Conference
BU
10/14Pandemic Pets Push Industry Stocks to Pricey Valuations
DJ
More news
News in other languages on ZOETIS
11/05EN DIRECT DES MARCHES : ArcelorMittal, Société Générale, Veolia, CGG, Lufthansa,..
11/05Insoutenable
11/02ZOETIS : publication des résultats trimestriels
11/02ZOETIS : Veröffentlichung des Quartalsergebnisses
08/12Il va y avoir comme un problème
More news
Analyst Recommendations on ZOETIS
More recommendations
Chart ZOETIS
Duration : Period :
Zoetis Technical Analysis Chart | ZTS | US98978V1035 | MarketScreener
Technical analysis trends ZOETIS
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 180,88 $
Last Close Price 160,19 $
Spread / Highest target 31,1%
Spread / Average Target 12,9%
Spread / Lowest Target -22,0%
EPS Revisions
Managers
NameTitle
Kristin C. Peck Chief Executive Officer & Director
Mike B. McCallister Non-Executive Chairman
Roxanne Lagano Chief Human Resources Officer
Glenn C. David Chief Financial Officer & Executive Vice President
Catherine Ann Knupp Executive VP, President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
ZOETIS21.04%76 133
ELANCO ANIMAL HEALTH INCORPORATED7.91%14 997
DECHRA PHARMACEUTICALS PLC9.59%4 580
JINYU BIO-TECHNOLOGY CO., LTD.31.30%4 210
VIRBAC-9.51%2 149
TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD.52.32%1 340